To read the Quick Start Guide for myViSafe, please click here
ViMove2 consumables, modules and devices can be ordered from the ViMove2 online store. Please click here to go to the ViMove2 online store.
Yes. In this instance, the Monitoring session data will be stored on the ViMove2 sensors and can be downloaded onto the clinician’s ViMove2 app once the patient returns to the clinic following their Monitoring session.
When the patient profile is created, an email will automatically be sent to your patient with details about how to download and log into the myViMove app. These details can be resent at any time by going into the patient’s profile and resending.
The ViMove2 app can be downloaded from the Apple App store. To do this, To download the app onto your compatible device, visit the Apple App Store, search for “ViMove2” and install the application onto your iOS-compatible device. Please refer to the following specification requirements to ensure your device can run ViMove2:
- iPad 4th generation (or newer)
- iPad Mini 2 (or newer)
- iOS 10.0.2 (or later)
A patient’s assessment report can be emailed as a PDF. To do this, select the assessment you’d like to send, click the “Share” button located at the top right hand corner of the screen, and follow the prompts to enter and email address and send.
- No light colour: Sensor is off.
- Flashing red: Sensor has between 6% and 19% charge.
- Flashing Yellow: Sensor has between 20% and 49% charge.
- Flashing Green: Sensor has between 50% and 99% charge.
- Solid Green: Sensor is fully charged.
The minimum running time for a rep to be recorded in ViMove2 Run is 10 seconds. The longer the assessment, the more representative the data will be.
During a Monitoring session, ViMove2 assesses sitting quality based on the patient’s prior Low Back Live Assessments, where data is captured on the patients usual normal, upright and slouched sitting positions. If no Live Assessment has been performed prior to the Monitoring session, the sitting data captured is compared to normative data based on the patient’s age.
The maximum ViMove2 Monitoring period is 24 hours.